Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension

Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension

Abstract Aims Sinus tachycardia potentially leads to a deterioration of cardiac function in critically ill infants. The ultrashort‐acting beta‐blocker landiolol hydrochloride is a new pharmacological option for a selective heart rate (HR) control in patients with sinus tachycardia and heart failure....

Full description

Bibliographic Details
Main Authors: Lukas Schroeder, Paulina Monno, Martin Unger, Jakob Ackerl, Olga Shatilova, Joachim Schmitt, Till Dresbach, Andreas Mueller, Florian Kipfmueller
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:ESC Heart Failure
Subjects:
Heart rate control
Landiolol hydrochloride
Cardiac dysfunction
Pulmonary hypertension
Online Access:https://doi.org/10.1002/ehf2.14202

Internet

https://doi.org/10.1002/ehf2.14202

Similar Items